A case report highlights profound thrombocytopenia associated with tirofiban in a patient with glucose-6-phosphate dehydrogenase deficiency during primary percutaneous coronary intervention. This finding underscores the need for caution when using tirofiban in patients with this genetic deficiency.
tirofiban associated profound thrombocytopenia in a patient with glucose 6 phosphate dehydrogenase deficiency undergoing primary percutaneous coronary intervention a case report
Original title: “Tirofiban-Associated Profound Thrombocytopenia in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Primary Percutaneous Coronary Intervention: A Case Report.”